Iassay, Inc

Website
4565 62nd St
San Diego, CA 92115
https://www.iassay.net

Iassay, Inc is a San Diego-based company that has developed the innovative iAssay System, a handheld platform that consolidates FDA cleared point of care cartridges and Health IT Clouds. This groundbreaking technology makes point of care testing practical for triaging and diagnosing patients, ultimately leading to lower healthcare costs and saving lives.

With a focus on COVID-19 healthcare providers and POCT manufacturers, Iassay, Inc aims to revolutionize the way healthcare is delivered by providing a comprehensive solution that streamlines diagnostic processes. Their patented system has garnered recognition and achievements, including being awarded two years in a row, and they continue to make strides in the field of healthcare technology.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Global Algae Innovations, Inc

Global Algae Innovations, Inc. is a leading manufacturer based in El Cajon, California, specializing in innovative algae solutions. With a focus on research and development, Global Algae Innovations is dedicated to harnessing the potential of algae for various applications, offering cutting-edge products and services to meet the evolving needs of industries worldwide.Generated from the website
Services, nec, nec

Anabios

Anabios, based in San Diego, specializes in providing human-focused drug discovery insights to expedite the creation of innovative therapeutics. Their cutting-edge translational technologies are designed to facilitate the development of novel treatments and enhance the drug discovery process. Generated from their website's infomation

Paramita Therapeutics, Inc

Paramita Therapeutics, Inc. is an early-stage biotech startup based in San Diego, CA, founded in 2018 by Drs. Sang Van and Jack Bui. Specializing in the development of targeted immunotherapies, Paramita utilizes their proprietary water-soluble multivalent conjugation platform technologies to combat cancer and infectious diseases, such as COVID-19. Despite facing setbacks due to the pandemic, Paramita secured pre-seed funding in 2018 and received a Phase 1 small business innovation research (SBIR) award from the National Science Foundation (NSF) in 2021. With a focus on developing dual-function therapeutic and vaccine products, Paramita aims to complete preclinical and toxicology studies for advanced prostate and ovarian cancer.Generated from the website
United States›California›San Diego›Iassay, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.